Form 4: Director Telman Acquires AtriCure Shares

Director Deborah H. Telman acquired 6,144 shares of AtriCure common stock through a Restricted Stock Award.

Summary

• Director Deborah H. Telman acquired 6,144 shares of AtriCure, Inc. common stock on May 18, 2026.
• The acquisition was made through a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan.
• These shares are subject to vesting upon the one-year anniversary of the grant date.
• Following this transaction, Telman beneficially owns 28,328 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine stock award to a director rather than a significant open market purchase or sale.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 6,144 shares by a director indicates continued alignment of management and shareholder interests.

Future Outlook

The shares acquired are subject to vesting upon the one-year anniversary of the grant date, indicating a future milestone for these shares.

Industry Context

StockSavvy.ai notes that director stock awards are a common form of executive compensation and incentive, designed to align leadership interests with those of shareholders. Such transactions are routine disclosures under SEC regulations.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as it aligns director interests with shareholders, though it is a form of compensation rather than an open market purchase.

Next Steps

• The acquired shares will vest upon the one-year anniversary of the grant date.

Key Dates

Keywords

AtriCure, ATRC, Form 4, Insider Trading, Restricted Stock Award, Director, Beneficial Ownership